Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management
Awgichew Shewasinad Yehualashet,1 Teshome Fentik Belachew,2 Zemene Demelash Kifle,3 Ayele Mamo Abebe4 1Pharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia; 2Department of Pharmacy, Debre Birhan Health Science College,...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-09-01
|
Series: | Vascular Health and Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/targeting-cardiac-metabolic-pathways-a-role-in-ischemic-management-peer-reviewed-article-VHRM |
id |
doaj-d7bf26f0c3844690a72719d36d43ce60 |
---|---|
record_format |
Article |
spelling |
doaj-d7bf26f0c3844690a72719d36d43ce602020-11-25T03:07:15ZengDove Medical PressVascular Health and Risk Management1178-20482020-09-01Volume 1635336556983Targeting Cardiac Metabolic Pathways: A Role in Ischemic ManagementYehualashet ASBelachew TFKifle ZDAbebe AMAwgichew Shewasinad Yehualashet,1 Teshome Fentik Belachew,2 Zemene Demelash Kifle,3 Ayele Mamo Abebe4 1Pharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia; 2Department of Pharmacy, Debre Birhan Health Science College, Debre Birhan, Ethiopia; 3School of Pharmacy, Department of Pharmacology, University of Gondar, Gondar, Ethiopia; 4Department of Nursing, College of Health Sciences, Debre Berhan University, Debre Berhan, EthiopiaCorrespondence: Awgichew Shewasinad YehualashetPharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, PO Box 445, Debre Berhan, EthiopiaTel +251-93-545-0290Email awgshewa@gmail.comAbstract: Among the vast number of noncommunicable diseases encountered worldwide, cardiovascular diseases accounted for about 17.8 million deaths in 2017 and ischemic heart disease (IHD) remains the single-largest cause of death in countries across all income groups. Because conventional medications are not without shortcomings and patients still refractory to these medications, scientific investigation is ongoing to advance the management of IHD, and shows a great promise for better treatment modalities, but additional research can warrant improvement in terms of the quality of life of patients. Metabolic modulation is one promising strategy for the treatment of IHD, because alterations in energy metabolism are involved in progression of the disease. Therefore, the purpose of this review was to strengthen attention toward the use of metabolic modulators and to review the current level of knowledge on cardiac energy metabolic pathways.Keywords: metabolic modulation, ischemic heart disease, cardiac energy metabolism, mitochondrial dynamicshttps://www.dovepress.com/targeting-cardiac-metabolic-pathways-a-role-in-ischemic-management-peer-reviewed-article-VHRMmetabolic modulationischemic heart diseasecardiac energy metabolismmitochondrial dynamics |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yehualashet AS Belachew TF Kifle ZD Abebe AM |
spellingShingle |
Yehualashet AS Belachew TF Kifle ZD Abebe AM Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management Vascular Health and Risk Management metabolic modulation ischemic heart disease cardiac energy metabolism mitochondrial dynamics |
author_facet |
Yehualashet AS Belachew TF Kifle ZD Abebe AM |
author_sort |
Yehualashet AS |
title |
Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management |
title_short |
Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management |
title_full |
Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management |
title_fullStr |
Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management |
title_full_unstemmed |
Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management |
title_sort |
targeting cardiac metabolic pathways: a role in ischemic management |
publisher |
Dove Medical Press |
series |
Vascular Health and Risk Management |
issn |
1178-2048 |
publishDate |
2020-09-01 |
description |
Awgichew Shewasinad Yehualashet,1 Teshome Fentik Belachew,2 Zemene Demelash Kifle,3 Ayele Mamo Abebe4 1Pharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia; 2Department of Pharmacy, Debre Birhan Health Science College, Debre Birhan, Ethiopia; 3School of Pharmacy, Department of Pharmacology, University of Gondar, Gondar, Ethiopia; 4Department of Nursing, College of Health Sciences, Debre Berhan University, Debre Berhan, EthiopiaCorrespondence: Awgichew Shewasinad YehualashetPharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, PO Box 445, Debre Berhan, EthiopiaTel +251-93-545-0290Email awgshewa@gmail.comAbstract: Among the vast number of noncommunicable diseases encountered worldwide, cardiovascular diseases accounted for about 17.8 million deaths in 2017 and ischemic heart disease (IHD) remains the single-largest cause of death in countries across all income groups. Because conventional medications are not without shortcomings and patients still refractory to these medications, scientific investigation is ongoing to advance the management of IHD, and shows a great promise for better treatment modalities, but additional research can warrant improvement in terms of the quality of life of patients. Metabolic modulation is one promising strategy for the treatment of IHD, because alterations in energy metabolism are involved in progression of the disease. Therefore, the purpose of this review was to strengthen attention toward the use of metabolic modulators and to review the current level of knowledge on cardiac energy metabolic pathways.Keywords: metabolic modulation, ischemic heart disease, cardiac energy metabolism, mitochondrial dynamics |
topic |
metabolic modulation ischemic heart disease cardiac energy metabolism mitochondrial dynamics |
url |
https://www.dovepress.com/targeting-cardiac-metabolic-pathways-a-role-in-ischemic-management-peer-reviewed-article-VHRM |
work_keys_str_mv |
AT yehualashetas targetingcardiacmetabolicpathwaysaroleinischemicmanagement AT belachewtf targetingcardiacmetabolicpathwaysaroleinischemicmanagement AT kiflezd targetingcardiacmetabolicpathwaysaroleinischemicmanagement AT abebeam targetingcardiacmetabolicpathwaysaroleinischemicmanagement |
_version_ |
1724671608093671424 |